Treatments for Epilepsy and Symptoms of
Data sourced from IRS 990 public filings
Treatments for Epilepsy and Symptoms of Tess Research Foundations goal is to find better treatment options for SLC13A5 deficiency, (Continued on Sch O)
Treatments for Epilepsy and Symptoms of has received 7 grants from 6 known foundation funders. Revenue increased from $503,647 in 2023 to $541,973 in 2024. Most recent reported revenue: $541,973.
Annual Revenue
$541,973
Known Funders
6
Grants Received
7
Financial History
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $541,973 | $584,239 | $407,310 |
| 2023 | $503,647 | $497,687 | $459,776 |
| 2022 | $610,734 | $868,351 | $447,207 |
| 2021 | $381,268 | $466,822 | $717,894 |
| 2020 | $675,901 | $113,779 | $798,282 |
| 2019 | $392,669 | $368,510 | $223,542 |
| 2018 | $286,889 | $172,923 | $198,894 |
| 2017 | $185,768 | $248,656 | $84,928 |
Top Funders
MENLO PARK, CA
MENLO PARK, CA
Mountain View, CA
WASHINGTON, DC
Washington, DC
SEATTLE, WA
Key Personnel
From 2024 IRS 990 filing
Amber Black
Secretary
Paula Gani
Director
Courtney Alberti
Director
Adam Alberti
Director
Lee Scheuer
Director
Robert Wassman
Director
Don Neault
Director
Janet Wojcicki
Director
Megan Gilbert
Director
Rich Windisch
Director
Showing 10 of 13 key personnel.
Frequently Asked Questions
Other Nonprofits in California
Unlock Full Nonprofit Data
Sign up for free to access the complete funder list, financial history, program details, key personnel, and smart matching.